Carbapenemases in Pseudomonas spp;Carbapenemasas en especies del género Pseudomonas

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue SUPPL. 1, 2010, Pages 19-28

  Nicolau, Carlos Juan ^a   Oliver, Antonio ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Carbapenemases; Metallo lactamases; Pseudomonas spp

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE; CEFTAZIDIME; CEPHALOSPORIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; ENZYME ASSAY; NONHUMAN; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS MENDOCINA; PSEUDOMONAS PSEUDOALCALIGENES; PSEUDOMONAS PUTIDA; PSEUDOMONAS STUTZERI;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; GENES, BACTERIAL; HUMANS; OPPORTUNISTIC INFECTIONS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; R FACTORS;

EID: 77049121809     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(10)70004-5     Document Type: Article

References (89)

1. a ed. (2000), Churchill Livingstone, Nueva York 1980-2003
2. Aloush V., Navon-Venezia S., Seigman-Igra Y., Cabili S., and Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother 50 (2006) 43-48
3. Lynch J.P. Hospital-acquired pneumonia: risk factors, microbiology, and treatment. Chest 119 Suppl 2 (2001) S373-S384
4. Vincent J.L. Nosocomial infections in adult intensive-care units. Lancet 361 (2003) 2068-2077
5. Mousa H.A. Aerobic, anaerobic and fungal burn wound infections. J Hosp Infect 37 (1997) 317-323
6. Gilligan P.H. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 4 (1991) 35-51
7. Martinez-Solano L., Macia M.D., Fajardo A., Oliver A., and Martinez J.L. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 47 (2008) 1526-1533
8. Juan C., Macia M.D., Gutierrez O., Vidal C., Perez J.L., and Oliver A. Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains. Antimicrob Agents Chemother 49 (2005) 4733-4738
9. Moya B., Dötsch A., Juan C., Blazquez J., Zamorano L., Haussler S., et al. Beta-lactam resistance response triggered by inactivation of a non-essential penicillin-binding protein. PLoS Pathog 5 (2009) e1000353
10. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis 34 (2002) 634-640
11. Mesaros N., Nordmann P., Plesiat P., Roussel-Delvallez M., van Eldere J., Glupczynski Y., et al. Pseudomonas aeruginosa: resistance and therapeutics options in the turn of the new millennium. Clin Microbiol Infect 13 (2007) 560-578
12. Macia M.D., Blanquer D., Togores B., Sauleda J., Perez J.L., and Oliver A. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 49 (2005) 3382-3386
13. Oliver A., Cantón R., Campo P., Baquero F., and Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288 (2000) 1251-1254
14. Pedersen S.S. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS Suppl 28 (1992) S1-S79
15. Souza Dias M.B., Habert A.B., Borrasca V., Stempliuk V., Ciolli A., Araujo M.R., et al. Salvage of long-term central venous catheters during an outbreak of Pseudomonas putida and Stenotrophomonas maltophilia infections associated with contaminated heparin catheter-lock solution. Infect Control Hosp Epidemiol 29 (2008) 125-130
16. Aumeran C., Paillard C., Robin F., Kanold J., Baud O., Bonnet R., et al. Pseudomonas aeruginosa and Pseudomonas putida outbreak associated with contaminated water outlets in an oncohaematology paediatric unit. J Hosp Infect 65 (2007) 47-53
17. Juan C, Zamorano L, Mena A, Albertí S, Perez JL, Oliver A. Metallo-β-lactamase (MBL)-producing Pseudomonas putida as a reservoir of multidrug-resistance elements that are efficiently amplified by transference to successful P. aeruginosa clones. J Antimicrob Chemother. 2009 (En prensa).
18. Gutiérrez O., Juan C., Cercenado E., Navarro F., Bouza E., Coll P., et al. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother 51 (2007) 4329-4335
19. Lister P.D., Wolter D.J., and Hanson N.D. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22 (2009) 582-610
20. Mushtaq S., Ge Y., and Livermore D.M. Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential. Antimicrob Agents Chemother 48 (2004) 3086-3092
21. Quale J., Bratu S., Gupta J., and Landman D. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 50 (2006) 1633-1641
22. Ambler R.P. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci 289 (1980) 321-331
23. Walsh T.R., Toleman M.A., Poirel L., and Nordmann P. Metallo-beta-lactamases: the quiet before the storm?. Clin Microbiol Rev 18 (2005) 306-325
24. Queenan A.M., and Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20 (2007) 440-458
25. Poirel L., Pitout J.D., and Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2 (2007) 501-512
26. Rodriguez-Martinez J.M., Poirel L., and Nordmann P. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob Agents Chemother 53 (2009) 1766-1771
27. Rodriguez-Martinez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009 Sep 8 [Epub ahead of print].
28. Giamarellou H., and Poulakou G. Multidrug-resistant Gram-negative infections: What are the treatment options?. Drugs 69 (2009) 1879-1901
29. Gales A.C., Jones R.N., and Sader H.S. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 12 (2006) 315-321
30. Bouza E., Garcia-Garrote F., Cercenado E., Marin M., and Diaz M.S. Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. Antimicrob Agents Chemother 43 (1999) 981-982
31. Sanchez-Romero I., Cercenado E., Cuevas O., Garcia-Escribano N., Garcia-Martinez J., Bouza E., et al. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: second national study. Rev Esp Quimioter 20 (2003) 222-229
32. Suarez C., Peña C., Campo A., Murillas J., Almirante B., Pomar V., et al. Impact of carbapenem-resistance on Pseudomonas aeruginosa (PA) bloodstream infections outcome. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (2009) Resumen: K-332
33. Rossolini G.M., Luzzaro F., Migliavacca R., Mugnaioli C., Pini B., de Luca F., et al. First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy. Antimicrob Agents Chemother 52 (2008) 4023-4029
34. Lee K., Park A.J., Kim M.Y., Lee H.J., Cho J.H., Kang J.O., et al. Metallo-beta-lactamaseproducing Pseudomonas spp. in Korea: high prevalence of isolates with VIM-2 type and emergence of isolates with IMP-1 type. Yonsei Med J 50 (2009) 335-339
35. Fritsche T.R., Sader H.S., Toleman M.A., Walsh T.R., and Jones R.N. Emerging metallo-betalactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program. Clin Infect Dis 41 Suppl 4 (2005) S276-S278
36. Bush K., Jacoby G.A., and Medeiros A.A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39 (1995) 211-233
37. Walther-Rasmussen J., and Høiby N. Class A carbapenemases. J Antimicrob Chemother 60 (2007) 470-482
38. Yigit H., Queenan A.M., Anderson G.J., Domenech-Sanchez A., Biddle J.W., Steward C.D., et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenemresistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45 (2001) 1151-1161 Erratum in: Antimicrob Agents Chemother. 2008;52:809
39. Villegas M.V., Lolans K., Correa A., Kattan J.N., Lopez J.A., Quinn J.P., et al. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenemhydrolyzing beta-lactamase. Antimicrob Agents Chemother 51 (2007) 1553-1555
40. Wolter D.J., Kurpiel P.M., Woodford N., Palepou M.F., Goering R.V., and Hanson N.D. Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4. Antimicrob Agents Chemother 53 (2009) 557-562
41. Poirel L., Le Thomas I., Naas T., Karim A., and Nordmann P. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 44 (2000) 622-632
42. Giakkoupi P., Tzouvelekis L.S., Tsakris A., Loukova V., Sofianou D., and Tzelepi E. IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob Agents Chemother 44 (2000) 2247-2253
43. Lee S.H., and Jeong S.H. Nomenclature of GES-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother 49 (2005) 2148
44. Jacoby G.A. Beta-lactamase nomenclature. Antimicrob Agents Chemother 50 (2006) 1123-1129
45. Poirel L., Weldhagen G.F., Naas T., de Champs C., Dove M.G., and Nordmann P. GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother 45 (2001) 2598-2603
46. Wang C., Cai P., Chang D., and Mi Z. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase. J Antimicrob Chemother 57 (2006) 1261-1262
47. Labuschagne C.J., Weldhagen G.F., Ehlers M.M., and Dove M.G. Emergence of class 1 integron-associated GES-5 and GES-5-like extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa in South Africa. Int J Antimicrob Agents 31 (2008) 527-530
48. Viedma E., Juan C., Acosta J., Zamorano L., Otero J.R., Sanz F., et al. Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain. Antimicrob Agents Chemother 53 (2009) 4930-4933
49. Poirel L., Brinas L., Fortineau N., and Nordmann P. Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49 (2005) 3593-3597
50. Yong D, Bell JM, Ritchie B, Pratt R, Toleman MA, Walsh TR, et al. A novel subgroup Metallo-β-lactamases (MBL) AIM-1 emerges in Pseudomonas aeruginosa (PSA) from Australia. En: Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2007. Abstract C1-593, p. 75. American Society for Microbiology. Washington, DC, USA.
51. Poirel L, Rodríguez-Martínez J, Al Naiemi N, Debets-Ossenkopp Y, Nordmann P, et al. Characterization of blaDIM-1, a novel integron-located metallo-beta-lactamase gene from a Pseudomonas stutzeri clinical isolate in Netherlands. En: Oral sessions of the 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, 2009. Session 0309, p. 61. European Society of Clinical Microbiology and Infectious Diseases. Basel, Switzerland.
52. Sekiguchi J., Morita K., Kitao T., Watanabe N., Okazaki M., Miyoshi-Akiyama T., et al. KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate. Antimicrob Agents Chemother 52 (2008) 4194-4197
53. Osano E., Arakawa Y., Wacharotayankun R., Ohta M., Horii T., Ito H., et al. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 38 (1994) 71-78
54. Docquier J.D., Riccio M.L., Mugnaioli C., Luzzaro F., Endimiani A., Toniolo A., et al. IMP-12, a new plasmid-encoded metallo-beta-lactamase from a Pseudomonas putida clinical isolate. Antimicrob Agents Chemother 47 (2003) 1522-1528
55. Pellegrini C., Mercuri P.S., Celenza G., Galleni M., Segatore B., Sacchetti E., et al. Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location. J Antimicrob Chemother 63 (2009) 901-908
56. Senda K., Arakawa Y., Ichiyama S., Nakashima K., Ito H., Ohsuka S., et al. PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol 34 (1996) 2909-2913
57. Shibata N., Doi Y., Yamane K., Yagi T., Kurokawa H., Shibayama K., et al. PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J Clin Microbiol 41 (2003) 5407-5413
58. Lauretti L., Riccio M.L., Mazzariol A., Cornaglia G., Amicosante A., Fontana R., et al. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 43 (1999) 1584-1590
59. Quinteira S., Ferreira H., and Peixe L. First isolation of blaVIM-2 in an environmental isolate of Pseudomonas pseudoalcaligenes. Antimicrob Agents Chemother 49 (2005) 2140-2141
60. Pournaras S., Ikonomidis A., Tzouvelekis L.S., Tokatlidou D., Spanakis N., Maniatis A.N., et al. VIM-12, a novel plasmid-mediated metallo-beta-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid. Antimicrob Agents Chemother 49 (2005) 5153-5156
61. Docquier J.D., Lamotte-Brasseur J., Galleni M., Amicosante G., Frère J.M., and Rossolini G.M. On functional and structural heterogeneity of VIM-type metallo-beta-lactamases. J Antimicrob Chemother 51 (2003) 257-266
62. Zavascki A.P., Gaspareto P.B., Martins A.F., Gonçalves A.L., and Barth A.L. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-(beta)-lactamase in a teaching hospital in southern Brazil. J Antimicrob Chemother 56 (2005) 1148-1151
63. Martins A.F., Zavascki A.P., Gaspareto P.B., and Barth A.L. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil. Infection 35 (2007) 457-460
64. El Salabi A., Toleman M.A., Weeks J., Bruderer T., Frei R., and Walsh T.R. First report of the metallo-β-lactamase, SPM-1, in Europe. Antimicrob Agents Chemother (2009) [Epub ahead of print]
65. Castanheira M., Toleman M.A., Jones R.N., Schmidt F.J., and Walsh T.R. Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallobeta- lactamase. Antimicrob Agents Chemother 48 (2004) 4654-4661
66. Lee K., Yum J.H., Yong D., Lee H.M., Kim H.D., Docquier J.D., et al. Novel acquired metallobeta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49 (2005) 4485-4491
67. Walther-Rasmussen J., and Høiby N. OXA-type carbapenemases. J Antimicrob Chemother 57 (2006) 373-383
68. Paterson D.L., and Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18 (2005) 657-686
69. Naas T., and Nordmann P. OXA-type beta-lactamases. Curr Pharm Des 5 (1999) 865-879
70. Paton R., Miles R.S., Hood J., Amyes S.G., Miles R.S., and Amyes S.G. ARI 1: beta-lactamasemediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 2 (1993) 81-87
71. Sevillano E., Gallego L., and Garcia-Lobo J.M. First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. Pathol Biol (Paris) 57 (2009) 493-495
72. Girlich D., Naas T., and Nordmann P. Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob Agents Chemother 48 (2004) 2043-2048
73. Kong K.F., Jayawardena S.R., del Puerto A., Wiehlmann L., Laabs U., Tümmler B., et al. Characterization of poxB, a chromosomal-encoded Pseudomonas aeruginosa oxacillinase. Gene 358 (2005) 82-92
74. Lee K., Chong Y., Shin H.B., Kim Y.A., Yong D., and Yum J.H. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 7 (2001) 88-91
75. Lee K., Lim Y.S., Yong D., Yum J.H., and Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 41 (2003) 4623-4629
76. Jesudason M.V., Kandathil A.J., and Balaji V. Comparison of two methods to detect carbapenemase & metallo-beta-lactamase production in clinical isolates. Indian J Med Res 121 (2005) 780-783
77. Noyal M.J., Menezes G.A., Harish B.N., Sujatha S., and Parija S.C. Simple screening tests for detection of carbapenemases in clinical isolates of non-fermentative Gram-negative bacteria. Indian J Med Res 129 (2009) 707-712
78. Yong D., Lee K., Yum J.H., Shin H.B., Rossolini G.M., and Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 40 (2002) 3798-3801
79. Walsh T.R., Bolmström A., Qwärnström A., and Gales A. Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing. J Clin Microbiol 40 (2002) 755-759
80. Yan J.J., Wu J.J., Tsai S.H., and Chuang C.L. Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-beta-lactamases in gram-negative bacilli. Diagn Microbiol Infect Dis 49 (2004) 5-11
81. Al Naiemi N., Debets-Ossenkopp Y.J., Lee P.S., Savelkoul P., and Vandenbroucke-Grauls C. Appropriate Müller-Hinton agar is crucial for the performance of metallo-lactamase Etest. 19th European Congress of Clinical Microbiology and Infectious Diseases. Helsinki (2009) Abstract number: P812
82. Prats G., Miro E., Mirelis B., Poirel L., Bellais S., and Nordmann P. First isolation of a carbapenem-hydrolyzing beta-lactamase in Pseudomonas aeruginosa in Spain. Antimicrob Agents Chemother 46 (2002) 932-933
83. Peña C., Suarez C., Tubau F., Gutierrez O., Dominguez A., Oliver A., et al. Nosocomial spread of Pseudomonas aeruginosa producing the metallo-beta-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications. Clin Microbiol Infect 13 (2007) 1026-1029
84. Juan C., Beceiro A., Gutierrez O., Alberti S., Garau M., Perez J.L., et al. Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain. Antimicrob Agents Chemother 52 (2008) 3589-3596
85. Empel J., Filczak K., Mrówka A., Hryniewicz W., Livermore D.M., and Gniadkowski M. Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum betalactamase in Warsaw, Poland: further evidence for an international clonal complex. J Clin Microbiol 45 (2007) 2829-2834
86. Lopez-Otsoa F., Gallego L., Towner K.J., Tysall L., Woodford N., and Livermore D.M. Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain. J Clin Microbiol 40 (2002) 4741-4743
87. Gutierrez-Urbon O., Requena-Rodriguez M.J., Diaz-Antolin P., and Oliver-Palomo A. Isolation of multi-resistant carbapenemase-producing Pseudomonas aeruginosa (VIM-2) and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (SHV-2) in a perianal ulcer in a patient with hematological disease. Enferm Infecc Microbiol Clin 23 (2005) 574-575
88. Rodriguez M.C., Ruiz del Castillo B., Rodriguez-Mirones C., Romo M., Monteagudo I., and Martinez-Martinez L. Molecular characterization of Pseudomonas aeruginosa isolates in Cantabria, Spain, producing VIM-2 metallo-beta-lactamase. Enferm Infecc Microbiol Clin (2009) [Epub ahead of print]
89. Juan C., Gutierrez O., Renom F., Garau M., Gallegos C., Alberti S., et al. Chronic respiratory infections by mucoid carbapenemase-producing Pseudomonas aeruginosa strains, a new potential public health problem. Antimicrob Agents Chemother 52 (2008) 2285-2286